Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats

BACKGROUND: Accumulative data links inflammation and immune dysregulation to the pathophysiology of mental disorders; little is known regarding leukotrienes’ (LTs) involvement in this process. Circumstantial evidence suggests that treatment with leukotriene modifying agents (LTMAs) such as monteluka...

Descripción completa

Detalles Bibliográficos
Autores principales: Rostevanov, Ira S., Betesh-Abay, Batya, Nassar, Ahmad, Rubin, Elina, Uzzan, Sarit, Kaplanski, Jacob, Biton, Linoy, Azab, Abed N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487911/
https://www.ncbi.nlm.nih.gov/pubmed/36148246
http://dx.doi.org/10.3389/fimmu.2022.981440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487911/
https://www.ncbi.nlm.nih.gov/pubmed/36148246
http://dx.doi.org/10.3389/fimmu.2022.981440

Ejemplares similares